Year 2017 / Volume 109 / Number 8
Editorial
The complexity of evaluating and increasing adherence in inflammatory bowel disease

539-541

DOI: 10.17235/reed.2017.5143/2017

Petra Weimers, Johan Burisch, Pia Munkholm,

Abstract
Inflammatory bowel diseases (IBDs), due to their chronic and progressive nature, require lifelong treatment to relief and/or prevent inflammation and symptoms, obtaining mucosal healing at best. Therefore, adherence to treatment is an essential topic to address when treating patients with IBD. Nonetheless, adherence remains a common and complex issue in IBD care. Patient characteristics such as young age, male sex and employment has previously been verified as possible predictors of non-adherence. Additionally, evaluating adherence in itself is a challenge since both accurate and easy-to-use screening tools as well as golden standards are lacking.
Share Button
New comment
Comments
No comments for this article
References
1. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003;114(1):39–43.
2. Severs M, Zuithoff PNPA, Mangen M-JJ, et al. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Sep;22(9):2158–64.
3. Kane S V., Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001 Oct;96(10):2929–33.
4. De Castro M-L, Sanromán L, Martín A, et al. Assessing medication adherence in Inflammatory Bowel Diseases. A comparison between a self-administered scale and a pharmacy refill index. Spanish J Gastroenterol. 2017;In press.
5. Kane S, Becker B, Scott Harmsen W, et al. Use of a Screening Tool to Determine Nonadherent Behavior in Inflammatory Bowel Disease. Am J Gastroenterol. 2012;107(10).
6. Bermejo F, López-San Román A, Algaba A, et al. Factors that modify therapy adherence in patients with inflammatory bowel disease. J Crohn’s Colitis. 2010;4:422–6.
7. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006 Mar;23(5):577–85.
8. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6(5):592–9.
9. Algaba A, Guerra I, García García de Paredes A, et al. What is the real-life maintenance mesalazine dose in ulcerative colitis? Rev Española Enfermedades Dig. 2016 Feb;109(2):114–21.
10. Robinson A. Review article: improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008 Feb 28;27:9–14.
11. Greenley RN, Kunz JH, Walter J, et al. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jun;19(7):1534–45.
12. Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided “Constant-care” approach. Gut. 2010 Dec;59(12):1652–61.
13. Cross RK, Cheevers N, Rustgi A, et al. A Randomized, Controlled Trial of Home Telemanagement in Patients with Ulcerative Colitis (UC HAT). Inflamm Bowel Dis. 2012;18(6):1018.
14. Hommel KA, Hente E, Herzer M, et al. Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study. Eur J Gastroenterol Hepatol. 2013 Apr;25(4):469–73.
15. Carlsen K, Jakobsen C, Houen G, et al. Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Feb;1.
16. Pedersen N, Elkjaer M, Duricova D, et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther. 2012 Nov;36(9):840–9.
17. Pedersen N, Thielsen P, Martinsen L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014 Dec;20(12):2276–85.
18. Elkjaer M, Burisch J, Avnstrøm S, et al. Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol. 2009 Jun;22(6):1.
19. de Jong M, van der Meulen-de Jong A, Romberg-Camps M, et al. Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD. Inflamm Bowel Dis. 2017 Apr;23(4):485–93.
20. Bager P, Julsgaard M, Vestergaard T, et al. Scandinavian Journal of Gastroenterology Adherence and quality of care in IBD Adherence and quality of care in IBD. Scand J Gastroenterol. 2016;5111:1326–31.
Related articles

Letter

Hepatosplenic T-cell lymphoma and inflammatory bowel disease

DOI: 10.17235/reed.2023.9472/2023

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Apoptotic colopathy as a manifestation of Good’s syndrome

DOI: 10.17235/reed.2021.8297/2021

Original

Radon exposure and inflammatory bowel disease in a radon prone area

DOI: 10.17235/reed.2021.8239/2021

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Editorial

Is celiac disease really associated with inflammatory bowel disease?

DOI: 10.17235/reed.2019.6779/2019

Original

Megacolon in inflammatory bowel disease: response to infliximab

DOI: 10.17235/reed.2020.6394/2019

Editorial

Diet in the etiology of inflammatory bowel disease

DOI: 10.17235/reed.2018.6119/2018

Case Report

Serrated Lesions in patients with Inflammatory Bowel Disease.

DOI: 10.17235/reed.2019.5910/2018

Editorial

Online social networks and inflammatory bowel disease

DOI: 10.17235/reed.2018.5496/2018

Letter to the Editor

Idiopathic portal hypertension with regard to thiopurine treatment

DOI: 10.17235/reed.2018.5256/2017

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Citation tools
Weimers P, Burisch J, Munkholm P. The complexity of evaluating and increasing adherence in inflammatory bowel disease. 5143/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 850 visits.
This article has been downloaded 155 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 27/06/2017

Accepted: 06/07/2017

Online First: 14/07/2017

Published: 31/07/2017

Article Online First time: 17 days

Article editing time: 34 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology